1,000
Participants
Start Date
March 15, 2022
Primary Completion Date
August 31, 2027
Study Completion Date
January 31, 2028
LIVERguard
The LIVERguard is an FDA cleared and is a CE-marked medical device intended to be used for the static hypothermic preservation of livers during transportation and eventual transplantation into a recipient using cold storage solutions indicated for use with the liver. The intended organ storage time for the LIVERguard is up to 16 hours.
Duke University, Durham
University of Florida, Gainesville
Tampa General Hospital, Tampa
University of Alabama at Birmingham, Birmingham
University of Nebraska, Omaha
Stanford University, Stanford
University of Washington, Seattle
Lead Sponsor
Paragonix Technologies
INDUSTRY